LNDC Landec Corp.

Lifecore Biomedical Appoints Brikkelle Thompson as Senior Vice President of Human Resources

Lifecore Biomedical Appoints Brikkelle Thompson as Senior Vice President of Human Resources

Ms. Thompson Brings Nearly 25 Years of HR Leadership Driving Top Performing Cultures and Building Exceptional Teams

CHASKA, Minn., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced the appointment of Brikkelle Thompson as senior vice president of human resources. Ms. Thompson brings nearly 25 years of visionary human resources leadership, global experience, and deep talent management to Lifecore, including 14 years in the medical technology, medical device, and healthcare industries. She will be charged with enhancing the company’s performance-driven culture, while further strengthening the Lifecore team by maintaining and securing exceptional talent.

“As we continue to sharpen and execute our growth strategy to maximize value for our stakeholders, we are keenly aware that our corporate culture and team will be essential to successfully achieving our vision for the business. In Brikkelle, we have added an exceptional HR executive who has a well-earned reputation for elevating companies by building teams with top-level talent from across the country while fostering performance-driven cultures,” said Paul Josephs, president and chief executive officer. “We feel fortunate to add Brikkelle as a strategic partner to our operations team and are eager to see the important contributions she makes in aligning our mission, values, culture, and team toward our ultimate goal of consistent and meaningful growth.”

Ms. Thompson has a successful track record of partnering with organizational leaders to architect and deliver HR strategies to optimize the employee experience and enhance organizational performance. Her leadership spans from small organizations to Fortune 100 companies in public and private sectors. Prior to joining Lifecore, she held the position of head of human resources – the Americas at Teleflex. Ms. Thompson has also served as vice president of human resources for Nonin Medical, where she reported directly into the CEO and instituted an HR Business Partner model that positioned HR as the strategic, proactive and collaborative partner to company-wide leadership. Her career also includes nearly a decade tenure with Medtronic, where she held the position of global executive development program manager, as well as serving as talent development consultant.

About Lifecore Biomedical

Lifecore Biomedical, Inc. (Nasdaq: ) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the Company, visit Lifecore’s website at .



Lifecore Biomedical, Inc. Contact Information:

Vida Strategic Partners
Stephanie Diaz (Investors)
415-675-7401
 

Tim Brons (Media)
415-675-7402
 
EN
10/09/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Landec Corp.

 PRESS RELEASE

Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Res...

Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update -- Recorded Revenues of $24.7 Million for Q1 Fiscal 2025 -- -- Signed Multiple New Business Agreements with New and Existing Customers -- -- More than Doubled Capacity with Installation of 5-Head Isolator Filler; Increased Revenue Generating Potential to Up to $300 Million Annually -- -- Successfully Closed Financing Raising Approx. $24.3 Million, Providing Financial Runway for Current Liquidity Needs and Future Growth -- Conference Call Today at 8:30 a.m. ET CHASKA, Minn., Oct. 04...

 PRESS RELEASE

Lifecore Biomedical Raises $24.3 Million in Private Placement of Commo...

Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock PIPE with New and Existing Investors Supports Working Capital and Operations CHASKA, Minn., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced the closing of a $24.3 million private placement (“PIPE”) of 5,928,775 shares of its common stock at a price of $4.10 per share. The investing group includes new and existing shareholders, and the company expects to use the proceeds for working capital...

 PRESS RELEASE

Lifecore Biomedical to Report Financial Results for First Quarter of F...

Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024 CHASKA, Minn., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it will report financial results for the first quarter of fiscal year 2025 on Friday, October 4, 2024, prior to market open and will host a webcast at 8:30 a.m. Eastern Time. Members of Lifecore’s senior management team will discuss financial results for the first quarter...

 PRESS RELEASE

Lifecore Biomedical Selected by Lindy Biosciences to Support Process D...

Lifecore Biomedical Selected by Lindy Biosciences to Support Process Development and Commercial Scale-Up for Innovative Microglassification Formulation Technology Multi-Million Dollar Development Agreement Establishes Lifecore as Lindy Biosciences’ Preferred CDMO Offers Lifecore Key Access Point into Manufacture and Fill/Finish of Next-Generation Biotherapeutic Formulations with Potential to Deliver Significant Benefits to Patients Worldwide CHASKA, Minn., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated contract development and m...

 PRESS RELEASE

Lifecore Biomedical to Participate at Upcoming Industry Conferences an...

Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events CHASKA, Minn., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate at four upcoming industry events. Details of the company’s activities at these events are as follows: Medical Aesthetic Injectable Summit 2024Conference Date/Location: October 4-5, 2024, in Marbella, SpainDetails: Darren Hieber, Lifecore’s senior vice president of corporate develo...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch